Sichuan Hebang Biotechnology Co Ltd (603077) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Sichuan Hebang Biotechnology Co Ltd (603077) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥165.40 Million ≈ $24.20 Million USD) by net assets (CN¥18.77 Billion ≈ $2.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603077 stock market capitalisation for the company's overall valuation and market capitalisation.

Sichuan Hebang Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Sichuan Hebang Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sichuan Hebang Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Hebang Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Sichuan Hebang Biotechnology Co Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Digitalbridge Group Inc NYSE:DBRG	0.018x
Stadler Rail AG SW:SRAIL	0.008x
ASPEN PHAR.UN.ADR /1 O.N. F:LDZU	N/A
National HealthCare Corporation NYSE MKT:NHC	0.058x
Relay Therapeutics Inc NASDAQ:RLAY	-0.080x
Guangzhou Haozhi Industrial Co Ltd SHE:300503	0.011x
LG Household & Healthcare KO:051900	0.016x
KPJ Healthcare Bhd KLSE:5878	0.074x

Annual Cash Flow Conversion Efficiency for Sichuan Hebang Biotechnology Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. View Sichuan Hebang Biotechnology Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥17.96 Billion ≈ $2.63 Billion	CN¥1.08 Billion ≈ $157.49 Million	0.060x	+143.42%
2024-12-31	CN¥19.01 Billion ≈ $2.78 Billion	CN¥467.93 Million ≈ $68.47 Million	0.025x	+147.94%
2023-12-31	CN¥20.22 Billion ≈ $2.96 Billion	CN¥200.76 Million ≈ $29.38 Million	0.010x	-92.58%
2022-12-31	CN¥19.76 Billion ≈ $2.89 Billion	CN¥2.64 Billion ≈ $386.94 Million	0.134x	-38.74%
2021-12-31	CN¥14.64 Billion ≈ $2.14 Billion	CN¥3.20 Billion ≈ $467.78 Million	0.218x	+569.51%
2020-12-31	CN¥11.31 Billion ≈ $1.65 Billion	CN¥368.85 Million ≈ $53.97 Million	0.033x	+129.32%
2019-12-31	CN¥11.45 Billion ≈ $1.68 Billion	CN¥162.92 Million ≈ $23.84 Million	0.014x	-83.13%
2018-12-31	CN¥11.20 Billion ≈ $1.64 Billion	CN¥944.39 Million ≈ $138.19 Million	0.084x	+437.35%
2017-12-31	CN¥11.27 Billion ≈ $1.65 Billion	CN¥176.94 Million ≈ $25.89 Million	0.016x	-70.60%
2016-12-31	CN¥10.78 Billion ≈ $1.58 Billion	CN¥575.26 Million ≈ $84.18 Million	0.053x	-21.77%
2015-12-31	CN¥6.58 Billion ≈ $963.21 Million	CN¥449.20 Million ≈ $65.73 Million	0.068x	+58.44%
2014-12-31	CN¥4.75 Billion ≈ $695.38 Million	CN¥204.67 Million ≈ $29.95 Million	0.043x	+134.78%
2013-12-31	CN¥3.29 Billion ≈ $481.46 Million	CN¥-407.48 Million ≈ $-59.63 Million	-0.124x	-412.44%
2012-12-31	CN¥3.40 Billion ≈ $498.22 Million	CN¥134.96 Million ≈ $19.75 Million	0.040x	-90.38%
2011-12-31	CN¥1.34 Billion ≈ $196.21 Million	CN¥552.56 Million ≈ $80.86 Million	0.412x	+21.42%
2010-12-31	CN¥974.62 Million ≈ $142.62 Million	CN¥330.77 Million ≈ $48.40 Million	0.339x	+262.97%
2009-12-31	CN¥737.62 Million ≈ $107.94 Million	CN¥68.97 Million ≈ $10.09 Million	0.094x	--

About Sichuan Hebang Biotechnology Co Ltd

SHG:603077 China Chemicals

Market Cap

$2.95 Billion

CN¥20.14 Billion CNY

Market Cap Rank

#5021 Global

#871 in China

Share Price

CN¥2.28

Change (1 day)

-0.44%

52-Week Range

CN¥1.91 - CN¥3.33

All Time High

CN¥4.69